ArticleAnnals of medicine and surgery (2012)2026
Artificial intelligence models for survival prediction in colorectal cancer: a systematic review of time-to-event approaches.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, with marked heterogeneity in patient survival. Conventional clinicopathologic staging provides limited individualized prognostic information. Artificial intelligence (AI) and machine learning methods have enabled survival-aware modeling approaches that integrate complex clinical, imaging, and molecular data to improve time-to-event survival prediction. This systematic review aimed to synthesize current evidence on AI-based models for survival prediction in CRC. Methods: A systematic search of PubMed, Scopus, Web of Science Core Collection, IEEE Xplore, and Google Scholar was conducted in accordance with the PRISMA 2020 guidelines. Studies were included if they applied AI methods to model time-to-event survival outcomes in CRC. Records were independently screened, data were extracted, and risk of bias and applicability were assessed using the PROBAST + AI tool. Results: Eight retrospective cohort studies published between 2021 and 2025, encompassing 11 811 patients, met the inclusion criteria. The included studies evaluated diverse data modalities, including clinical variables, radiomics, histopathology, transcriptomics, and genomics. Model performance was moderate to high, with concordance index values ranging from approximately 0.70 to 0.85. All studies demonstrated effective risk stratification of patients into distinct survival groups. Models incorporating high-dimensional imaging or molecular data generally outperformed those based on clinical variables alone. The overall risk of bias was low to unclear, with no study rated as high risk. Conclusion: AI-based time-to-event survival models demonstrate potential prognostic value for prognostic stratification in CRC. Further prospective studies, standardized reporting, and external validation are required to support clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.